These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25229169)

  • 21. Quality of life in patients with partial-onset seizures under adjunctive therapy with zonisamide: results from a prospective non-interventional surveillance study.
    Helmstaedter C; Stefan H; Witt JA
    Epileptic Disord; 2011 Sep; 13(3):263-76. PubMed ID: 21914589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zonisamide: Review of Recent Clinical Evidence for Treatment of Epilepsy.
    Kwan SY; Chuang YC; Huang CW; Chen TC; Jou SB; Dash A
    CNS Neurosci Ther; 2015 Sep; 21(9):683-91. PubMed ID: 26205514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [ZONISAMIDE: FIRST CHOICE AMONG THE FIRST-LINE ANTIEPILEPTIC DRUGS IN FOCAL EPILEPSY].
    Janszky J; Horvath R; Komoly S
    Ideggyogy Sz; 2015 May; 68(5-6):149-53. PubMed ID: 26182605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zonisamide in the management of epilepsy in the elderly.
    Romigi A; Femia EA; Fattore C; Vitrani G; Di Gennaro G; Franco V
    Clin Interv Aging; 2015; 10():931-7. PubMed ID: 26089654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of zonisamide: our experience.
    Yamauchi T; Aikawa H
    Seizure; 2004 Dec; 13 Suppl 1():S41-8; discussion S49. PubMed ID: 15511689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zonisamide: its pharmacology, efficacy and safety in clinical trials.
    Brodie MJ; Ben-Menachem E; Chouette I; Giorgi L
    Acta Neurol Scand Suppl; 2012; (194):19-28. PubMed ID: 23106522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zonisamide in the management of epilepsy--Japanese experience.
    Ohtahara S
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S25-33. PubMed ID: 16321507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy, tolerability, and retention rates of zonisamide in older adult patients with focal-onset epilepsy: Experiences from two tertiary epilepsy centers.
    Doğan EA; Genç E; Genç BO; Erdoğan Ç
    Epilepsy Behav; 2017 Nov; 76():19-23. PubMed ID: 28927711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A long-term follow-up of zonisamide monotherapy.
    Fukushima K; Seino M
    Epilepsia; 2006 Nov; 47(11):1860-4. PubMed ID: 17116025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Practical prescribing and long-term efficacy and safety of zonisamide.
    Leppik IE
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S17-24. PubMed ID: 16406743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical experience with zonisamide monotherapy and adjunctive therapy in children with epilepsy at a tertiary care referral center.
    Kim HL; Aldridge J; Rho JM
    J Child Neurol; 2005 Mar; 20(3):212-9. PubMed ID: 15832611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zonisamide: a new antiepileptic drug.
    Oommen KJ; Mathews S
    Clin Neuropharmacol; 1999; 22(4):192-200. PubMed ID: 10442247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zonisamide in children and young adults with refractory epilepsy: an open label, multicenter Italian study.
    Coppola G; Grosso S; Verrotti A; Parisi P; Luchetti A; Franzoni E; Mangano S; Pelliccia A; Operto FF; Iannetti P; Curatolo P; Balestri P; Pascotto A
    Epilepsy Res; 2009 Feb; 83(2-3):112-6. PubMed ID: 19081227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilization of zonisamide in patients with chronic pain or epilepsy refractory to other treatments: a retrospective, open label, uncontrolled study in a VA hospital.
    Hasegawa H
    Curr Med Res Opin; 2004 May; 20(5):577-80. PubMed ID: 15140322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of zonisamide: results of a multicenter study.
    Leppik IE; Willmore LJ; Homan RW; Fromm G; Oommen KJ; Penry JK; Sackellares JC; Smith DB; Lesser RP; Wallace JD
    Epilepsy Res; 1993 Feb; 14(2):165-73. PubMed ID: 8453952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized phase III trial of adjunctive zonisamide in pediatric patients with partial epilepsy.
    Guerrini R; Rosati A; Segieth J; Pellacani S; Bradshaw K; Giorgi L
    Epilepsia; 2013 Aug; 54(8):1473-80. PubMed ID: 23837461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of zonisamide on weight. A clinical study in 103 patients with epilepsy.
    Wellmer J; Wellmer S; Bauer J
    Acta Neurol Scand; 2009 Apr; 119(4):233-8. PubMed ID: 19053955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term cognitive and mood effects of zonisamide monotherapy in epilepsy patients.
    Park SP; Hwang YH; Lee HW; Suh CK; Kwon SH; Lee BI
    Epilepsy Behav; 2008 Jan; 12(1):102-8. PubMed ID: 17945539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of zonisamide monotherapy in children with epilepsy.
    Seki T; Kumagai N; Maezawa M
    Seizure; 2004 Dec; 13 Suppl 1():S26-32; discussion S33. PubMed ID: 15511685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zonisamide: newer antiepileptic agent with multiple mechanisms of action.
    Biton V
    Expert Rev Neurother; 2004 Nov; 4(6):935-43. PubMed ID: 15853520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.